Driven To Cure

The executive summary for "Driven To Cure" is a call to action to raise awareness and funding for the research of rare kidney cancers, specifically HLRCC, in children and young adults. The organization seeks to support institutions such as the National Cancer Institute at NIH, Yale Smilow Cancer Center, Georgetown Lombardi Cancer Center, and David Geffen School of Medicine at UCLA in their efforts to find new cures for rare kidney cancers. The founder, Andrew Lee, personally experiencing the effects of HLRCC, emphasizes the need for continued collaboration and research to help those suffering from rare kidney cancers and their families.